# Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

> **NCT01005368** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 600 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** fluorescence in situ hybridization
- **GENETIC:** mutation analysis
- **GENETIC:** nucleic acid sequencing
- **GENETIC:** polymerase chain reaction
- **GENETIC:** western blotting
- **OTHER:** flow cytometry
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01005368
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005368, "Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01005368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*